Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.510
+0.080 (5.59%)
At close: Sep 22, 2026, 4:00 PM EDT
1.530
+0.020 (1.32%)
Pre-market: Sep 23, 2026, 8:02 AM EDT
Imunon Market Cap
Imunon has a market cap or net worth of $8.47 million as of September 22, 2026. Its market cap has decreased by -22.26% in one year.
Market Cap
8.47M
Enterprise Value
9.45M
1-Year Change
-22.26%
Ranking
Category
Stock Price
$1.51
ChartMarket Cap Chart
Since March 1, 1999, Imunon's market cap has decreased from $37.70M to $8.47M, a decrease of -77.52%. That is a compound annual growth rate of -5.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 8.47M | -27.58% |
| Dec 31, 2025 | 11.70M | -15.22% |
| Dec 31, 2024 | 13.80M | 115.63% |
| Dec 29, 2023 | 6.40M | -36.00% |
| Dec 30, 2022 | 10.00M | -78.59% |
| Dec 31, 2021 | 46.70M | 75.56% |
| Dec 31, 2020 | 26.60M | -31.62% |
| Dec 31, 2019 | 38.90M | 47.35% |
| Dec 31, 2018 | 26.40M | -38.60% |
| Dec 29, 2017 | 43.00M | 444.30% |
| Dec 30, 2016 | 7.90M | -82.29% |
| Dec 31, 2015 | 44.60M | -4.09% |
| Dec 31, 2014 | 46.50M | -12.10% |
| Dec 31, 2013 | 52.90M | -81.56% |
| Dec 31, 2012 | 286.80M | 531.72% |
| Dec 30, 2011 | 45.40M | 73.95% |
| Dec 31, 2010 | 26.10M | -34.09% |
| Dec 31, 2009 | 39.60M | 77.58% |
| Dec 31, 2008 | 22.30M | -30.75% |
| Dec 31, 2007 | 32.20M | 57.07% |
| Dec 29, 2006 | 20.50M | -52.87% |
| Dec 30, 2005 | 43.50M | -52.51% |
| Dec 31, 2004 | 91.60M | -52.76% |
| Dec 31, 2003 | 193.90M | 367.23% |
| Dec 31, 2002 | 41.50M | -26.29% |
View and export this data all the way back to 1999. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exicure | 8.38M |
| CollPlant Biotechnologies | 8.32M |
| Skye Bioscience | 8.19M |
| Soligenix | 8.06M |
| Evogene | 8.03M |
| XTL Biopharmaceuticals | 7.87M |
| CNS Pharmaceuticals | 7.86M |
| Traws Pharma | 7.76M |